<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2024-3767</article-id><article-id custom-type="edn" pub-id-type="custom">UTQYUB</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3767</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТРЕСС В ПОПУЛЯЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>STRESS IN THE POPULATION</subject></subj-group></article-categories><title-group><article-title>Медиатор острой фазы воспаления интерлейкин-6 и депрессия, стресс на рабочем месте среди лиц молодого возраста (25-44 лет)</article-title><trans-title-group xml:lang="en"><trans-title>Acute phase mediator interleukin-6 and depression, work-related stress among young people (25-44 years old)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5701-7856</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гафаров</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gafarov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гафаров Валерий Васильевич — д.м.н., профессор, заслуженный деятель науки РФ, г.н.с., руководитель лаборатории психологических и социологических проблем терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">valery.gafarov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8313-3893</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Елена Алексеевна — д.м.н., ведущий научный сотрудник лаборатории психологических и социологических проблем терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">elena.a.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2268-4186</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каштанова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kashtanova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каштанова Елена Владимировна — д.б.н., доцент, зав. лаборатории клинических биохимических и гормональных исследований терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">elekastanova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5255-5647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гагулин</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gagulin</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гагулин Игорь Вячеславович — старший научный сотрудник лаборатории психологических и социологических проблем терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">gagulin@ngs.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3538-0280</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полонская</surname><given-names>Я. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polonskaya</surname><given-names>Y. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полонская Яна Владимировна — д.б.н., старший научный сотрудник, лаборатории клинических биохимических и гормональных исследований терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">yana-polonskaya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5380-9434</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гафарова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gafarova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гафарова Альмира Валерьевна — к.м.н., старший научный сотрудник лаборатории психологических и социологических проблем терапевтических заболеваний.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">alma77@ngs.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4936-8362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рагино</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ragino</surname><given-names>Yu. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рагино Юлия Игоревна — д.м.н., профессор, член-корр. РАН, руководитель филиала.</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">ragino@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт терапии и профилактической медицины — филиал ФГБНУ "Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения РАН"</institution></aff><aff xml:lang="en"><institution>Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>29</day><month>01</month><year>2024</year></pub-date><volume>23</volume><issue>2</issue><fpage>3767</fpage><lpage>3767</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гафаров В.В., Громова Е.А., Каштанова Е.В., Гагулин И.В., Полонская Я.В., Гафарова А.В., Рагино Ю.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гафаров В.В., Громова Е.А., Каштанова Е.В., Гагулин И.В., Полонская Я.В., Гафарова А.В., Рагино Ю.И.</copyright-holder><copyright-holder xml:lang="en">Gafarov V.V., Gromova E.A., Kashtanova E.V., Gagulin I.V., Polonskaya Y.V., Gafarova A.V., Ragino Y.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3767">https://cardiovascular.elpub.ru/jour/article/view/3767</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить ассоциацию уровня интерлейкина-6 (ИЛ-6) с депрессией и стрессом на работе среди лиц молодого возраста (25-44 лет) г. Новосибирска.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследована случайная репрезентативная выборка лиц молодого возраста (25-44 лет) г. Новосибирска (975 лиц обоего пола, отклик составил 71%) в 2013-2016гг на базе НИИТПМ — филиале ИЦиГ СО РАН (бюджетная тема FWNR-2024-0002). Все респонденты подписали информированное согласие на участие в исследовании. Для оценки депрессии использовалась шкала программы Всемирной организации здравоохранения "MONICA-психосоциальная (MOPSY)"; стресс на работе определяли по шкале Каразека, входящей в протокол программы. Количественное определение ИЛ-6 выполнено в лаборатории клинических биохимических и гормональных исследований терапевтических заболеваний НИИТПМ — филиале ИЦиГ СО РАН.</p></sec><sec><title>Результаты</title><p>Результаты. Высокие уровни депрессии (ВУД) среди лиц обоего пола 25-44 лет составили 11,9% (среди мужчин — 8,5%, среди женщин — 14,6%). Уровень ИЛ-6 был выше у лиц обоего пола при ВУД — 1,33 [0,72;3,92] пг/мл, чем с отсутствием депрессии — 1,16 [0,63;2,37] пг/мл) (p=0,002). У женщин с ВУД содержание ИЛ-6 было выше — 1,31 [0,72;3,86] пг/мл, чем с отсутствием депрессии — 1 [0,53;2,03] пг/мл или среднем уровне депрессии — 1,06 [0,58;2,14] пг/мл, (p=0,002). Уровень ИЛ-6 был выше среди лиц обоего пола, у которых в течение последних 12 мес. произошла смена специальности — 1,4 [0,67;3,58] пг/мл, чем среди тех, у кого изменений не было — 1,12 [0,63;2,04] пг/мл. Среди участников исследования, оценивающих свою ответственность на работе как очень высокую, медианные показатели содержания сывороточного ИЛ-6 были более высокими — 1,7 [0,72;5,48] пг/мл, чем среди лиц с высокой нагрузкой на работе — 1,37 [0,58;5,18] пг/мл, а также со средней нагрузкой — 1,21 [0,63;2,5] пг/мл и незначительной нагрузкой на рабочем месте — 1,09 [0,63;1,98] пг/мл.</p></sec><sec><title>Заключение</title><p>Заключение. Установлен достоверно более высокий уровень ИЛ-6 при депрессии и при стрессе на работе среди лиц молодого возраста (25-44 лет) в сравнении с лицами без депрессии и не испытывающих стресс на рабочем месте.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the association of interleukin-6 (IL-6) levels with depression and stress at work among young people (25-44 years old) in Novosibirsk.</p></sec><sec><title>Material and methods</title><p>Material and methods. A random representative sample of young people (25-44 years old) in Novosibirsk was surveyed (975 people of both sexes; response rate, 71%) in 2013-2016 on the basis of Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics (FWNR-2024-0002). All respondents signed informed consent. The World Health Organization MONICA-Psychosocial (MOPSY) scale was used to assess depression. Work-related stress was determined using the Karasek’s scale included in the program protocol. Quantitative determination of IL-6 was carried out in the laboratory of clinical biochemical and hormonal studies of therapeutic diseases of the Research Institute of Internal and Preventive Medicine — branch of the Institute of Cytology and Genetics.</p></sec><sec><title>Results</title><p>Results. High level of depression among people of both sexes aged 25-44 years were 11,9% (among men — 8,5%, among women — 14,6%). The level of IL-6 was higher in individuals of both sexes with high level of depression — 1,33 [0,72;3,92] pg/ml than without depression — 1,16 [0,63;2,37] pg/ml) (p=0,002). In women with high level of depression, IL-6 value was higher (1,31 [0,72;3,86] pg/ml) than in those without depression (1 [0,53;2,03] pg/ml) or a moderate depression — 1,06 [0,58;2,14] pg/ml, (p=0,002). The level of IL-6 was higher among people of both sexes who had changed occupation within the last 12 months (1,4 [0,67;3,58] pg/ml) than among those who had no changes — 1,12 [0,63;2,04] pg/ml. Among participants who assessed their work responsibility as very high, the median levels of serum IL-6 were higher (1,7 [0,72;5,48] pg/ml), than among people with high work load (1,37 [0,58;5,18] pg/ml), as well as with a moderate (1,21 [0,63;2,5] pg/ml) and a slight (1,09 [0,63;1,98] pg/ml) work load.</p></sec><sec><title>Conclusion</title><p>Conclusion. A significantly higher level of IL-6 was found in depression and workplace stress among young people (25-44 years old) compared to people without depression and not experiencing workplace stress.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>интерлейкин-6</kwd><kwd>депрессия</kwd><kwd>стресс на рабочем месте</kwd><kwd>лица молодого возраста</kwd></kwd-group><kwd-group xml:lang="en"><kwd>interleukin-6</kwd><kwd>depression</kwd><kwd>workplace stress</kwd><kwd>young people</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гафаров В. В., Громова Е. А., Гагулин И. В. и др. Гендерные особенности риска развития сердечно-сосудистых заболеваний у населения с симптомами депрессии в Сибири (программа ВОЗ "MONICA-психосоциальная"). Терапевтический архив. 2017;(9):60-7. doi:10.17116/terarkh201789960-67.</mixed-citation><mixed-citation xml:lang="en">Gafarov VV, Gromova EA, Gagulin IV, et al. Gender characteristics of the risk of developing cardiovascular diseases in the population with symptoms of depression in Siberia (WHO program "MONICA-psychosocial"). Therapeutic archive. 2017;(9):60-7. (In Russ.) doi:10.17116/terarkh201789960-67.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Шишкова В. Н., Котова М. Б. Психоэмоциональные факторы риска хронических неинфекционных заболеваний в амбулаторной практике. Методические рекомендации для терапевтов. Кардиоваскулярная терапия и профилактика.2022;21(10):3438. doi:10.15829/1728-8800-2022-3438.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Shishkova VN, Kotova MB. Psycho-­emotional risk factors for chronic non-infectious diseases in outpatient practice. Methodological recommendations for therapists. Cardio­vascular Therapy and Prevention. 2022;21(10):3438. (In Russ.) doi:10.15829/1728-8800-2022-3438.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wu Q, Kling JM. Depression and the Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort Studies. Medicine (Baltimore). 2016;6:e2815. doi:10.1097/MD.0000000000002815.</mixed-citation><mixed-citation xml:lang="en">Wu Q, Kling JM. Depression and the Risk of Myocardial Infarction and Coronary Death: A Meta-Analysis of Prospective Cohort Studies. Medicine (Baltimore). 2016;6:e2815. doi:10.1097/MD.0000000000002815.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coro­nary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Out­comes Research: endorsed by the American Psychiatric As­so­cia­tion. Circulation. 2008;17:1768-75. doi:10.1161/CIRCULATIONAHA.108.190769.</mixed-citation><mixed-citation xml:lang="en">Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and coro­nary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Out­comes Research: endorsed by the American Psychiatric As­so­cia­tion. Circulation. 2008;17:1768-75. doi:10.1161/CIRCULATIONAHA.108.190769.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;2:171-86. doi:10.1097/PSY.0b013e3181907c1b.</mixed-citation><mixed-citation xml:lang="en">Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;2:171-86. doi:10.1097/PSY.0b013e3181907c1b.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kaptoge S, Di Angelantonio E, et al. C-reactive protein con­centration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375: 132-40. doi:10.1016/S0140-6736(09)61717-7.</mixed-citation><mixed-citation xml:lang="en">Kaptoge S, Di Angelantonio E, et al. C-reactive protein con­centration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375: 132-40. doi:10.1016/S0140-6736(09)61717-7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ting EY, Yang AC, Tsai SJ. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020;6:2194. doi:10.3390/ijms21062194.</mixed-citation><mixed-citation xml:lang="en">Ting EY, Yang AC, Tsai SJ. Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci. 2020;6:2194. doi:10.3390/ijms21062194.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Boku S, Nakagawa S, Toda H, et al. Neural basis of major depressive disorder: Beyond monoamine hypothesis. Psychiatry Clin Neurosci. 2018;1:3-12. doi:10.1111/pcn.12604.</mixed-citation><mixed-citation xml:lang="en">Boku S, Nakagawa S, Toda H, et al. Neural basis of major depressive disorder: Beyond monoamine hypothesis. Psychiatry Clin Neurosci. 2018;1:3-12. doi:10.1111/pcn.12604.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Maes M. The cytokine hypothesis of depression: inflammation, oxidative &amp; nitrosative stress (IO&amp;NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett. 2008;23:287-91.</mixed-citation><mixed-citation xml:lang="en">Maes M. The cytokine hypothesis of depression: inflammation, oxidative &amp; nitrosative stress (IO&amp;NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett. 2008;23:287-91.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflammation. 2021;18:45. doi:10.1186/s12974-021-02100-7.</mixed-citation><mixed-citation xml:lang="en">Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflammation. 2021;18:45. doi:10.1186/s12974-021-02100-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-57. doi:10.1016/j.biopsych.2009.09.033.</mixed-citation><mixed-citation xml:lang="en">Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-57. doi:10.1016/j.biopsych.2009.09.033.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (tnf-alpha) and soluble interleukin-2 receptors (sil-2r) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. J Affect Disord. 2012;139:230-9. doi:10.1016/j.jad.2011.08.003.</mixed-citation><mixed-citation xml:lang="en">Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (tnf-alpha) and soluble interleukin-2 receptors (sil-2r) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. J Affect Disord. 2012;139:230-9. doi:10.1016/j.jad.2011.08.003.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chocano-Bedoya PO, Mirzaei F, O’Reilly EJ, et al. C-reactive protein, interleukin-6, soluble tumor necrosis factor alpha receptor 2 and incident clinical depression. J Affect Disord. 2014;163:25-32. doi:10.1016/j.jad.2014.03.023.</mixed-citation><mixed-citation xml:lang="en">Chocano-Bedoya PO, Mirzaei F, O’Reilly EJ, et al. C-reactive protein, interleukin-6, soluble tumor necrosis factor alpha receptor 2 and incident clinical depression. J Affect Disord. 2014;163:25-32. doi:10.1016/j.jad.2014.03.023.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Krishnan V. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 2007;131:391-404. doi:10.1016/j.cell.2007.09.018.</mixed-citation><mixed-citation xml:lang="en">Krishnan V. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell. 2007;131:391-404. doi:10.1016/j.cell.2007.09.018.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84-90. doi:10.1177/070674370605100204.</mixed-citation><mixed-citation xml:lang="en">Patten SB, Wang JL, Williams JV, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry. 2006;51:84-90. doi:10.1177/070674370605100204.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;4:219-21. doi:10.1503/jpn.150205.</mixed-citation><mixed-citation xml:lang="en">Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;4:219-21. doi:10.1503/jpn.150205.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575-86. doi:10.1016/S0140-6736(13)61611-6.</mixed-citation><mixed-citation xml:lang="en">Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575-86. doi:10.1016/S0140-6736(13)61611-6.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bühl A, Zöfel P. SPSS Version 10. Einführung in die moderne Datenanalyse unter Windows. Addison-­Wesley, 2000. 734 p. ISBN 3827316731, 9783827316738.</mixed-citation><mixed-citation xml:lang="en">Bühl A, Zöfel P. SPSS Version 10. Einführung in die moderne Datenanalyse unter Windows. Addison-Wesley, 2000. 734 p. ISBN 3827316731, 9783827316738.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Шальнова С. А., Евстифеева С. Е., Деев А. Д. и др. Распространенность тревоги и депрессии в различных регионах Российской Федерации и ее ассоциации с социально-демографическими факторами (по данным исследования ЭССЕ-РФ). Терапевтический архив. 2014;(12):53-60. doi:10.17116/terarkh2014861253-60.</mixed-citation><mixed-citation xml:lang="en">Shalnova SA, Evstifeeva SE, Deev AD, et al. The prevalence of anxiety and depression in different region of the Russian Federation and its association with sociodemographic factors (according to the data of the ESSE-RF study). Terapevticheskii Arkhiv. 2014;(12):53-60. (In Russ.) doi:10.17116/terarkh2014861253-60.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rai D, Zitko P, Jones K, et al. Country- and individual-­level so­cioeconomic determinants of depression: multilevel cross-national comparison. Br J Psychiatry. 2013;202:195-203. doi:10.1192/bjp.bp.112.112482.</mixed-citation><mixed-citation xml:lang="en">Rai D, Zitko P, Jones K, et al. Country- and individual-level so­cioeconomic determinants of depression: multilevel cross-national comparison. Br J Psychiatry. 2013;202:195-203. doi:10.1192/bjp.bp.112.112482.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bekhbat M, Neigh GN. Sex differences in the neuro-immune consequences of stress: focus on depression and anxiety. Brain Behav Immun. 2018;67:1-12. doi:10.1016/j.bbi.2017.02.006.</mixed-citation><mixed-citation xml:lang="en">Bekhbat M, Neigh GN. Sex differences in the neuro-immune consequences of stress: focus on depression and anxiety. Brain Behav Immun. 2018;67:1-12. doi:10.1016/j.bbi.2017.02.006.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Derry HM, Padin AC, Kuo JL, et al. Sex differences in depression: does inflammation play a role? Curr Psychiatr Rep. 2015;10:78. doi:10.1007/s11920-015-0618-5.</mixed-citation><mixed-citation xml:lang="en">Derry HM, Padin AC, Kuo JL, et al. Sex differences in depression: does inflammation play a role? Curr Psychiatr Rep. 2015;10:78. doi:10.1007/s11920-015-0618-5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Tao H, Chen X, Zhou H, et al. Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression. Front Psychol. 2020;11:1271. doi:10.3389/fpsyg.2020.01271.</mixed-citation><mixed-citation xml:lang="en">Tao H, Chen X, Zhou H, et al. Changes of Serum Melatonin, Interleukin-6, Homocysteine, and Complement C3 and C4 Levels in Patients With Depression. Front Psychol. 2020;11:1271. doi:10.3389/fpsyg.2020.01271.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Piantella S, Dragano N, McDonald SJ, et al. Depression symptoms mediate the association between workplace stress and interleukin 6 in women, but not men: The Whitehall II study. Brain Behav Immun Health. 2021;12:100215. doi:10.1016/j.bbih.2021.100215.</mixed-citation><mixed-citation xml:lang="en">Piantella S, Dragano N, McDonald SJ, et al. Depression symptoms mediate the association between workplace stress and interleukin 6 in women, but not men: The Whitehall II study. Brain Behav Immun Health. 2021;12:100215. doi:10.1016/j.bbih.2021.100215.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Maes M, Scharpé S, Meltzer H, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993;49:11-27. doi:10.1016/0165-1781(93)90027-e.</mixed-citation><mixed-citation xml:lang="en">Maes M, Scharpé S, Meltzer H, et al. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res. 1993;49:11-27. doi:10.1016/0165-1781(93)90027-e.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Vogelzangs N, de Jonge P, Smit J, et al. Cytokine production capacity in depression and anxiety. Transl. Psychiatry. 2016;6:e825. doi:10.1038/tp.2016.92.</mixed-citation><mixed-citation xml:lang="en">Vogelzangs N, de Jonge P, Smit J, et al. Cytokine production capacity in depression and anxiety. Transl. Psychiatry. 2016;6:e825. doi:10.1038/tp.2016.92.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
